IP Library Granted Patent US 8,853,414
Granted Patent B2
US 8,853,414 · App. 13/581,857 · Granted Oct 7, 2014

Process for producing pyripyropene derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,853,414
App. No.
13/581,857
Granted
Oct 7, 2014
Kind
B2
Abstract

Disclosed is a process for efficiently producing pyripyropene derivatives having acyloxy at the 1-position and 11-position and hydroxyl at the 7-position. The process comprises selectively acylating hydroxyl at the 1-position and 11-position of a compound represented by formula B1 through one to three steps with an acylating agent in the presence or absence of a base.

Claims (6)

1. A method for isolating and purifying a solvate crystal of a compound C represented by formula C:

wherein R represents a straight chain, branched chain, or cyclic C 2-6 alkylcarbonyl, provided that, when the alkyl moiety in the alkylcarbonyl group is of a branched chain or cyclic type, then R represents C 3-6 alkylcarbonyl,

the method comprising the step of:

(a) extracting a reaction solution containing compound C with an organic solvent selected from the group consisting of methyl acetate, ethyl acetate, butyl acetate, toluene, ethylbenzene, chlorobenzene, chloroform, dichloromethane, diethyl ether, diisopropyl ether, tetrahydrofuran, and dioxane and concentrating the extract after or without drying to obtain the isolated and purified solvate crystal of the compound C;

(b) evaporating a reaction solution containing compound C to dryness to give a crude product, then dissolving the crude product in an organic solvent selected from the group consisting of methyl acetate, ethyl acetate, butyl acetate, toluene, ethylbenzene, chlorobenzene, chloroform, dichloromethane, diethyl ether, diisopropyl ether, tetrahydrofuran, dioxane, methanol, and ethanol at room temperature or under heating to obtain an organic solvent solution, then precipitating the solvate crystal of the compound C from the organic solvent solution, and then filtering the precipitate to obtain the isolated and purified solvate crystal of the compound C; or

(c) evaporating a reaction solution containing compound C to dryness to give a crude product, dissolving the crude product in an organic solvent selected from the group consisting of methyl acetate, ethyl acetate, butyl acetate, toluene, ethylbenzene, chlorobenzene, chloroform, dichloromethane, diethyl ether, diisopropyl ether, tetrahydrofuran, dioxane, methanol, and ethanol at room temperature or under heating to obtain an organic solvent solution, adding a poor solvent selected from the group consisting of heptane, hexane, and cyclohexane to the organic solvent solution to obtain a combined solvent solution, then precipitating the solvate crystal of the compound C from the combined solvent solution, and then filtering the precipitate to obtain the isolated and purified solvate crystal of the compound C.

Assignments (4)
CHANGE OF NAME Recorded Feb 7, 2024
From: MITSUI CHEMICALS AGRO, INC.
To: MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC.
Reel/Frame 066508/0493 →
COMPANY SPLIT Recorded Jun 30, 2022
From: MEIJI SEIKA PHARMA CO., LTD.
To: MMAG CO., LTD.
Reel/Frame 060951/0847 →
CHANGE OF ADDRESS Recorded Jun 30, 2022
From: MMAG CO., LTD.
To: MMAG CO., LTD.
Reel/Frame 060951/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2012
From: FUKUDA, YOSHIMASA; ANDO, TAKASHI; GOTO, KIMIHIKO; NAKANISHI, NOZOMU; WATANABE, TAKASHI; KURIHARA, KENICHI; MINOWA, NOBUTO; MITOMI, MASAAKI
To: MEIJI SEIKA PHARMA CO., LTD.
Reel/Frame 029271/0030 →